Home / Market News / $VC
benzinga Corporate Catalyst Impact 55/100 ● negative

UBS Maintains Buy on Visteon, Lowers Price Target to $107

Oct 7, 2026, 9:17 PM UTC · Primary ticker $VC

UBS analyst Joseph Spak reiterated a 'Buy' rating on Visteon but reduced the price target from $130 to $107. This indicates a continued positive outlook on the company's long-term prospects despite a more conservative near-term valuation.

UBS analyst Joseph Spak maintained a 'Buy' rating on Visteon, signaling continued confidence in the company's fundamentals. However, the price target was lowered from $130 to $107, suggesting a recalibration of valuation expectations, possibly due to broader market conditions, sector-specific headwinds, or revised growth projections. This news primarily affects Visteon shareholders and potential investors, as it provides an updated professional assessment of the stock's value. In the short term, the lowered price target could exert some downward pressure on the stock, but the maintained 'Buy' rating suggests long-term optimism. The key risk for traders is potential short-term volatility, while the opportunity lies in assessing if the new price target reflects a more realistic valuation, potentially offering a better entry point for long-term investors.

$VC negative Price target lowered
Source: benzinga
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only.